Brief: CompuGroup Medical Sees 2024 Adjusted EBITDA At EUR 270 Mln - 310 Mln
Feb 7 (Reuters) - COMPUGROUP MEDICAL SE & CO KGAA
COP1n.DE :
* CGM DRIVES DIGITIZATION IN THE HEALTHCARE SECTOR AND
SIGNIFICANTLY INCREASES REVENUES AND OPERATING PROFIT MARGIN
* GUIDANCE 2024: ORGANIC REVENUE GROWTH OF 4% - 6% AND
ADJUSTED
EBITDA OF EUR 270 MILLION TO EUR 310 MILLION
Source text for Eikon: ID:nEQ1wqv8da
Further company coverage: COP1n.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on CompuGroup Medical SE & Co KgaA
See all newsBrief: Nagarro to replace CompuGroup in Germany's TecDax, Stratec in SDAX
Brief: Compugroup Medical Delisting Effective 24 June 2025
Brief: Compugroup Medical SE & Co KGaA - Issues Joint Reasoned Statement Recommending Shareholders To Accept Cvc's Public Delisting Offer
Brief: Cvc Capital Partners - Acceptance Period For Public Delisting Offer To Shareholders Of Compugroup Begins
Brief: Caesar Bidco Says Intends To Offer Cash Consideration In Amount Of Eur 22.00 Per CompuGroup Medical Share